RE: News on P34 Sep 2022 17:38
obviously Lupozor works a company like Avion does not agree to spend $25m funding a phase 3 trial without doing a huge amount of due diligence, and not forgetting it has successfully past phase 2 trials in the past and also attracted a multi billion pharma company many years ago to come on bird as partner before they got taken over… huge interest in Lupozor hence two multibillion $ companies have partnered with them, and IMM hit £250m Mcap during the last phase 3 trial… if the phase 3 is successful we are talking life changing gains for all invested here many many multiples of todays near all time lows, the key that unlocks the value here is FDA approval, fingers crossed we get the meeting minutes this week, what’s for sure is it’s imminent, GL all for the week ahead